[PERSON]
Chronic Kidney Disease
Featured in 3 tracked stories · first seen
Situations
MannKind Furoscix ReadyFlow approval
2 clusters · 7 sources · last updated
Latest: MannKind's Furoscix ReadyFlow autoinjector receives US FDA approval
MannKind Corporation secured a $50 million private placement and received FDA approval for its Furoscix ReadyFlow auto‑injector in late July 2026. The financing, led by Frazier Life Sciences, will fund general corporate
Finerenone regulatory expansion and clinical use
2 clusters · 6 sources · last updated
Latest: Finerenone Label Expansion Broadens CKD Treatment and Elevates Pharmacist Role
In July 2026, the UK’s National Institute for Health and Care Excellence (NICE) issued draft guidance endorsing finerenone as a treatment option for adults with symptomatic chronic heart failure with preserved or mildly